|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-3.06/-3.60
|
企業價值
10.20M
|
資產負債 |
每股賬面淨值
1.79
|
現金流量 |
現金流量率
--
|
損益表 |
收益
22.05K
|
每股收益
0.00
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/16 23:15 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia. |